Find clinical trials for Eli Lilly. Search for Eli Lilly clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 107
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
for
Neoplasms, Healthy
Location: New York NY, Syracuse NY
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07258836
Phase 1, Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
for
Ulcerative Colitis, Ulcerative Colitis Chronic,
Location: Boston MA, Waltham MA, Hartford CT, New York NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 2 - 19
Code: NCT04844606
Phase 3, Recruiting
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
for
Obesity, Overweight
Location: Morehead City NC
Sponsor: Eli Lilly and Company
Sex: All
Age: 6 - 17
Code: NCT06672549
Phase 3, Recruiting
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
for
Breast Cancer, Solid Tumors, Adult
Location: Boston MA, New York NY, Fairfax VA, Tampa FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05768139
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
for
Ovarian Neoplasms, Endometrial Neoplasms,
Location: Mineola NY, New York NY, Columbus OH, Grand Rapids MI,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06400472
Phase 1, Recruiting
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Boston MA, The Bronx NY, New York NY, Burlington VT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05614739
Phase 1, Recruiting
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
for
Alzheimer Disease, Healthy
Location: Marlton NJ, Maitland FL, Lady Lake FL, Decatur GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 45 - 70+
Code: NCT06657768
Phase 1, Recruiting
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
for
Obesity, Overweight
Location: Gulfport MS, South Jordan UT
Sponsor: Eli Lilly and Company
Sex: All
Age: 12 - 17
Code: NCT06672939
Phase 3, Recruiting
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
for
Type 2 Diabetes
Location: New Haven CT, Hyde Park NY, Philadelphia PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 10 - 17
Code: NCT06739122
Phase 3, Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
for
Obesity, Overweight
Location: San Antonio TX
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 65
Code: NCT07738614
Phase 1, Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
for
Chronic Pain, Low Back Pain
Location: New Bedford MA, Waltham MA, Hamden CT, Duncansville PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07641504
Phase 2, Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
for
Osteoarthritis, Knee, Chronic Pain
Location: New Bedford MA, Waltham MA, Hamden CT, Rochester NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 40+
Code: NCT07641517
Phase 2, Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract